|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.48 CNY | -2.18% |
|
-7.19% | -10.42% |
| Apr. 26 | Rianlon Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 17 | Rianlon Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Tianjin Aolifu Biotechnology Co., Ltd. announced that it will raise CNY 30 million in an equity round of funding on November 6, 2023. The transaction will include participation from new investor, Rianlon Corporation with 50% post completion of the transaction. The company will issue funds at a post money valuation of CNY 60 million.
The company's registered capital will increase from CNY 2.5 million to CNY 5 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.42% | 839M | |
| +4.99% | 103B | |
| -1.80% | 65.6B | |
| +39.52% | 39.06B | |
| +12.91% | 37.58B | |
| +7.38% | 33.26B | |
| +7.49% | 19.22B | |
| +12.86% | 16.83B | |
| +7.73% | 15.03B | |
| +16.93% | 14.96B |
RIANLON CORPORATION 
